Back to search

Niu-Chang-Chih · 2022 · Research Article

High relevance

Clinical Benefits of Golden-Antrodia Camphorata Containing Antroquinonol in Liver Protection and Liver Fat Reduction After Alcoholic Hepatitis.

Antrodia camphorata

OncologyCognition & nervesLiver support
SpeciesNiu-Chang-Chih
JournalFrontiers in pharmacology
Year2022

Key points

  • Objective: It has been reported that antroquinonol extracted from Golden- Antrodia camphorate exerts protective effects on liver function both in vitro and in vivo
  • However, the protective effects of Golden- Antrodia camphorata on liver function have not been fully investigated in human clinical studies
  • Therefore, the present study aimed to evaluate the beneficial effects of Golden- Antrodia camphorata on hepatic function after alcohol consumption in human subjects
  • Methods: A total of 80 participants with increased γ-glutamyl transferase levels (60-180 U/L) were enrolled in the current study and were randomly divided into two groups
  • Results: At 12 weeks post the first Golden- Antrodia camphorata administration, the serum levels of aspartate aminotransferase (AST; p < 0.0001), alanine aminotransferase (ALT; p = 0.0002) and triglyceride ( p = 0.0158) were notably declined in the Golden- Antrodia camphorata treatment group compared with the placebo group
  • No clinically significant differences were observed between the Golden- Antrodia camphorata treatment and placebo groups in terms of general safety parameters

Metadata-grounded summary

Citation abstract

Objective: It has been reported that antroquinonol extracted from Golden- Antrodia camphorate exerts protective effects on liver function both in vitro and in vivo. However, the protective effects of Golden- Antrodia camphorata on liver function have not been fully investigated in human clinical studies. Therefore, the present study aimed to evaluate the beneficial effects of Golden- Antrodia camphorata on hepatic function after alcohol consumption in human subjects. Methods: A total of 80 participants with increased γ-glutamyl transferase levels (60-180 U/L) were enrolled in the current study and were randomly divided into two groups. Participants in the first group were orally administrated with 300 mg/day Golden- Antrodia camphorata (tablets), while those in the second group received placebo tablets for 12 weeks. Biochemical routine blood tests were performed at 6 and 12 weeks following the first administration. Results: At 12 weeks post the first Golden- Antrodia camphorata administration, the serum levels of aspartate aminotransferase (AST; p < 0.0001), alanine aminotransferase (ALT; p = 0.0002) and triglyceride ( p = 0.0158) were notably declined in the Golden- Antrodia camphorata treatment group compared with the placebo group. No clinically significant differences were observed between the Golden- Antrodia camphorata treatment and placebo groups in terms of general safety parameters. Conclusion: A statistically significant difference was obtained in the serum levels of AST, ALT and triglycerides between the Golden- Antrodia camphorata and placebo groups. However, no clinical significance was observed in any of the safety parameters examined. Overall, these findings indicated that treatment with Golden- Antrodia camphorata exerted protective effects on liver function.

Citation

Yen YT, Park JH, Kang SH, Su T, Cheng H, Wen WC, et al. (2022). Clinical Benefits of Golden-Antrodia Camphorata Containing Antroquinonol in Liver Protection and Liver Fat Reduction After Alcoholic Hepatitis. Frontiers in pharmacology https://doi.org/10.3389/fphar.2022.757494 PMID: 35800453

Open citation